Baxter International Inc.

Baxter International Inc.

BAX.SW
Baxter International Inc.CH flagSwiss Exchange
84.00
CHF
- -
- -
42.62BMarket Cap
Baxter International Inc.
BAX.SW
(Swiss Exchange)

Recent

price

84.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Baxter International Inc. is a global medical technology innovator, delivering a broad array of healthcare products and solutions across the world. The company’s comprehensive portfolio addresses critical needs in hospital and clinical settings, offering sterile intravenous therapies, advanced infusion pumps, and various administration sets. They provide vital parenteral nutrition support and related essential products. For specialized interventions, Baxter offers solutions for critical and acute care, including therapies for organ support, alongside specialized injectable pharmaceuticals and inhaled anesthetics. In the realm of surgery, the company provides biological products for hemostasis, tissue sealing, and adhesion prevention. Following the 2021 acquisition of Hillrom, their offerings expanded significantly to include smart hospital beds, operating room tables, lights, pendants, precision positioning devices, and advanced patient monitoring and diagnostic systems for respiratory therapy and physical assessment. Baxter continues to advance connected care through integrated digital health platforms, software, communication tools, and cutting-edge monitoring technologies, exemplified by recent innovations like the Welch Allyn Connex 360 Vital Signs Monitor. The company has recently undergone strategic portfolio adjustments, notably completing the divestiture of its Kidney Care business in early 2025. Operating through a direct sales force and a network of distributors, drug wholesalers, and specialty providers, Baxter serves hospitals, clinics, nursing homes, rehabilitation centers, and patients receiving care at home across more than 100 countries. Founded in 1931, the company maintains its headquarters in Deerfield, Illinois.